Cited by 351Medical Imaging Techniques and ApplicationsBreast Lesions and CarcinomasCancer Diagnosis and Treatment

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features

Berger, Kevin L., Nicholson, Siobhan A., Dehdashti, Farrokh, Siegel, Barry A.·2000·American Journal of Roentgenology

Open this paper in CoChat — free account

Abstract

Objective Our goal was to assess the sensitivity of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) for the detection of mucinous carcinoma and to determine the histologic features of these tumors that may affect lesion detectability. Materials and methods A retrospective review of all patients with mucinous carcinoma who had undergone FDG PET at our institution from 1995 through 1998 identified 25 patients with new or recurrent mucinous carcinoma at the time of PET. In 22 of these patients, tissue specimens available from either core biopsy or surgical resection allowed detailed histologic analysis. Results FDG PET revealed mucinous carcinoma in only 13 (59%) of 22 patients, resulting in an unusually high percentage (41%) of false-negative results. Two histologic features were found to be predictive of FDG PET results: tumor cellularity (p = 0.011) and the amount of mucin within the tumor mass (p = 0.009). There was a positive correlation between tumor FDG uptake and cellularity but a negative correlation with the amount of mucin. Conclusion FDG PET is limited in the evaluation of mucinous tumors, particularly in hypocellular lesions with abundant mucin.

Integrity signals

Registry

Crossref · 10.2214/ajr.174.4.1741005

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,524
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
Rigo, P., Paulus, P., Kaschten, B., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01249629 · Cited by 496
Histological Typing of Breast Tumors
Azzopardi, J. G., Chepick, O. F., Wh, H., Jafarey, N. A., Llombard-Bosch, A., Ozzello, L., Rilke, F. O., Sasano, N., Sobin, L. H., Sommers, S. C., et al. (1982) · Tumori Journal · doi:10.1177/030089168206800301 · Cited by 444
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
Vansteenkiste, J., Stroobants, S. G., Leyn, P. R. D., Dupont, P. J., Bogaert, J. G., Maes, A., Deneffe, G. J., KL, N., Verschakelen, J., Lerut, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2142 · Cited by 408
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Adler, L. P., Crowe, J. P., Al-Kaisi, N. K., & Sunshine, J. L. (1993) · Radiology · doi:10.1148/radiology.187.3.8497624 · Cited by 372
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Higashi, K., Clavo, A. C., & Wahl, R. L. (1993) · PubMed · Cited by 311
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Sundaresan, S. R., Patterson, G. A., & Cooper, J. D. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.2.9016218 · Cited by 310
Self-citation
Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography
Cohen, M. S., Arslan, N., Dehdashti, F., Doherty, G. M., Lairmore, T. C., Brunt, L. M., & Moley, J. F. (2001) · Surgery · doi:10.1067/msy.2001.118265 · Cited by 306
Self-citation
Staging recurrent metastatic colorectal carcinoma with PET.
Delbeke, D., Vitola, J. V., Sandler, M. P., Arildsen, R. C., Powers, T., Wright, J. K., Chapman, W. C., & Pinson, C. W. (1997) · PubMed · Cited by 292
Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
Ogunbiyi, O. A., Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Birnbaum, E. H., Fleshman, J. W., Read, T. E., Philpott, G. W., & Kodner, I. J. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303744 · Cited by 268
Self-citation

Show all 25 references

Research works printed but not linked: 1

Rosai J. Special techniques in surgical pathology. In: Rosai J, ed. Ackerman's surgical pathology , 8th ed. St. Louis: Mosby-Year Book, 1996: 31-62

Sorted by citations

Items 101–200 of 351

FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation
Shim, S. S., & Han, J. (2010) · Annals of Nuclear Medicine · doi:10.1007/s12149-010-0358-x · Cited by 30
PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer
Vikram, R. (2008) · Cancer Imaging · doi:10.1102/1470-7330.2008.9009 · Cited by 30
Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma
Purandare, N. C., Pramesh, C. S., Karimundackal, G., Jiwnani, S. S., Agrawal, A., Shah, S. A., Kulkarni, M., Laskar, S. G., & Rangarajan, V. (2014) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000137 · Cited by 29
Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
Koay, E. J., Katz, M. H. G., Wang, H., Wang, X., Prakash, L., Javle, M. M., Shroff, R. T., Fogelman, D. R., Avila, S., Zaid, M., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00001 · Cited by 29
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers
Malibari, N., Hickeson, M. P., & Lisbona, R. (2015) · PET Clinics · doi:10.1016/j.cpet.2015.03.008 · Cited by 29
PET/CT Pattern Analysis for Surgical Staple Line Recurrence in Patients With Colorectal Cancer
Shyn, P. B., Madan, R., Wu, C., Ertürk, Ş. M., & Silverman, S. G. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.2892 · Cited by 29
Positron emission tomography as a tool for translational research in oncology
STAHL, A., Wieder, H. A., Piert, M., Wester, H. J., Senekowitsch–Schmidtke, R., & Schwaiger, M. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.04.003 · Cited by 28
Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer
Kim, H. W., Won, K. S., Song, B., & Kang, Y. N. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-015-0327-3 · Cited by 28
Assessing the Value of 68Ga-FAPI PET/CT in Gastric Mucinous Adenocarcinoma or Signet Ring Cell Carcinoma.
Sun, Y.-Y., Xu, J.-Y., Qiao, Y., Zhang, J., Pan, H., Xu, X.-P., & Song, S.-L. (2024) · Radiology: Imaging Cancer · doi:10.1148/rycan.230195 · Cited by 25
Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer
Khandani, A. H., Whitney, K. D., Keller, S. M., Isasi, C. R., & Blaufox, M. D. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328013ebc5 · Cited by 26
Can [18F]F-FDG PET/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer?
Elekonawo, F. M. K., Starremans, B. J., Laurens, S. T., Bremers, A. J. A., de Wilt, J. H. W., Heijmen, L., & de Geus‐Oei, L. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02268-w · Cited by 25
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features
Germani, M. M., Borelli, B., Boraschi, P., Antoniotti, C., Ugolini, C., Urbani, L., Morelli, L., Fontanini, G., Masi, G., Cremolini, C., et al. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102382 · Cited by 27
The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations
Wong, R., Tie, J., Lee, M., Cohen, J. D., Wang, Y., Li, L., Ma, S. B., Christie, M., Kosmider, S., Tomasetti, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32117 · Cited by 24
Using FDG‐PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation
Zhou, S., Wong, T. Z., & Marks, L. B. (2004) · Medical Physics · doi:10.1118/1.1779372 · Cited by 24
Clinical Value of 18 F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin
Vos, N. D., Goethals, I., & Ceelen, W. P. (2014) · Acta chirurgica Belgica · doi:10.1080/00015458.2014.11681046 · Cited by 23
Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer
Çağlar, M., Yener, C., & Karabulut, E. (2014) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-014-1115-8 · Cited by 23
Novel influenza A (H1N1) infection: chest CT findings from 21 cases in Seoul, Korea
Shim, S. S., Kim, Y., & Ryu, Y. J. (2010) · Clinical Radiology · doi:10.1016/j.crad.2010.07.011 · Cited by 23
Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities
Snoeckx, A., Dendooven, A., Carp, L., Desbuquoit, D., Spinhoven, M. J., Lauwers, P., Schil, P. E. V., van Meerbeeck, J. P., & Parizel, P. M. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.07.037 · Cited by 23
Diagnostische Aussagekraft von 18F-FDG PET/CT, Sonografie und MRT
An, Y., Lee, D. H., Yoon, J., Lee, S. J., Kim, T. H., Kang, D. K., Kim, K. S., Jung, Y. S., & Yim, H. (2014) · Nuklearmedizin - NuclearMedicine · Cited by 21
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma—a literature review
Virarkar, M., Ganeshan, D., Gulati, A., Palmquist, S. M., Iyer, R. B., & Bhosale, P. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02847-2 · Cited by 21
PET/CT molecular imaging in abdominal oncology
Stahl, A. R., Wieder, H. A., Wester, H. J., Piert, M., Lordick, F., Ott, K., Rummeny, E. J., Schwaiger, M., & Weber, W. (2004) · Abdominal Imaging · doi:10.1007/s00261-003-0113-z · Cited by 21
PET/MR Imaging in Cancers of the Gastrointestinal Tract
Paspulati, R. M., & Gupta, A. B. (2016) · PET Clinics · doi:10.1016/j.cpet.2016.05.004 · Cited by 20
Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy
Chan, H.-P., Liu, W., Liou, W., Hu, C., Chiu, Y., & Peng, N. (2019) · In Vivo · doi:10.21873/invivo.11797 · Cited by 20
Hereditary Diffuse Gastric Cancer: A Family Diagnosis and Treatment
Onitilo, A. A., Aryal, G., & Engel, J. M. (2012) · Clinical Medicine & Research · doi:10.3121/cmr.2012.1071 · Cited by 20
18F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes
dos Anjos, D. A., Habr‐Gama, A., Vailati, B. B., Rossi, C. B., Coturel, A. E., Perez, R. O., Julião, G. P. S., de Sousa, J. B., & Buchpiguel, C. A. (2016) · Annals of Nuclear Medicine · doi:10.1007/s12149-016-1089-4 · Cited by 20
F-18 FDG PET/CT in Rectal Carcinoma
Grassetto, G., Marzola, M. C., Minicozzi, A., AL-NAHHAS, A. M., & Rubello, D. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318219b507 · Cited by 19
Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
O’Neill, H., Malik, V. K., Johnston, C. J., Reynolds, J. V., & O'Sullivan, J. N. (2019) · Pharmaceuticals · doi:10.3390/ph12010016 · Cited by 22
FDG PET and PET/CT for Colorectal Cancer
Delbeke, D., & Martin, W. H. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-062-1_6 · Cited by 19
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging
Khan, K. H., Athauda, A., Aitken, K. L., Cunningham, D., Watkins, D. J., Starling, N., Cook, G., Kalaitzaki, E., Chau, I., & Rao, S. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0222 · Cited by 19
Value of 18F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension
Ma, Q., Xin, J., Zhao, Z., Guo, Q., Yu, S., Xu, W., Liu, C., & Zhai, W. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.01.021 · Cited by 18
Efficiency of apparent diffusion coefficients in differentiation of colorectal tumor recurrences and posttherapeutical soft-tissue changes
Nural, M. S., Danacı, M., Soyucok, A., & Okumuş, N. Ö. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.05.025 · Cited by 18
Ciliated muconodular papillary tumor of the lung: 18F-FDG PET/CT findings of 15 cases
Onishi, Y., Ito, K., Motoi, N., Morita, T., WATANABE, S.-I. I., & Kusumoto, M. (2020) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01457-8 · Cited by 18
Clinical value of whole body fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer
Yang, Z., Pan, L., Cheng, J., Hu, S., Xu, J., Ye, D., & Zhang, Y. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.02989.x · Cited by 18
PET/CT in patients with liver lesions of different nature
Rachh, S., & Basu, S. K. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0061-3 · Cited by 18
Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer
Culverwell, A., Chowdhury, F. U., & Scarsbrook, A. F. (2012) · Abdominal Imaging · doi:10.1007/s00261-012-9855-9 · Cited by 17
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei
Dubreuil, J., Giammarile, F., Rousset, P., Bakrin, N., Passot, G., Isaac, S., Gléhen, O., & Skanjeti, A. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3347-z · Cited by 17
Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign
Cha, M. J., Lee, K. S., Kim, T. J., Kim, H. S., Kim, T. S., Chung, M. J., Kim, B. T., & Kim, Y. S. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0409 · Cited by 17
High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging
Panagiotidis, E., Datseris, I., Exarhos, D., Skilakaki, M. G., Skoura, E. V., & Bamias, A. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283506ae1 · Cited by 16
Clinical Utility of 18F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma
Das, J. P., Vargas, H. A., Ghafoor, S., Goh, A. C., & Ulaner, G. A. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.251561 · Cited by 17
Advances in positron emission tomography imaging for the GI tract
Pham, K. H., Ramaswamy, M. R., & Hawkins, R. A. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.124741 · Cited by 16
The Diagnostic Value of FDG-PET/CT for Urachal Cancer
Stokkel, L. E., Stokkel, M. P. M., Donswijk, M. L., Lahaye, M. J., Bekers, E. M., van Rhijn, B. W. G., & Mertens, L. S. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2021.03.002 · Cited by 15
The Clinical Use of PET/CT in the Evaluation of Melanoma
Keu, K. V., & Iagaru, A. H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-727-3_30 · Cited by 15
Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT
Sung, Y. M., Lee, K. S., Kim, B., Han, J., & Lee, E. J. (2005) · European Radiology · doi:10.1007/s00330-004-2604-x · Cited by 15
Comparison of the 18F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox?
McDermott, S., Kilcoyne, A., Wang, Y., Scott, J. A., Halpern, E. F., & Ackman, J. B. (2019) · Clinical Radiology · doi:10.1016/j.crad.2018.12.009 · Cited by 15
Can dynamic imaging, using 18 F-FDG PET/CT and CT perfusion differentiate between benign and malignant pulmonary nodules?
Marin, A., Murchison, J. T., Skwarski, K. M., Tavares, A., Fletcher, A. J., Wallace, W. A., Salapura, V., van Beek, E. J. R., & Mirsadraee, S. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0024 · Cited by 15
PET-Based Radiation Therapy Planning
Speirs, C. K., Grigsby, P. W., Huang, J., Thorstad, W. L., Parikh, P. J., Robinson, C. G., & Bradley, J. D. (2014) · PET Clinics · doi:10.1016/j.cpet.2014.09.003 · Cited by 14
Imaging patterns of liver uptakes on PET scan: pearls and pitfalls
Luk, W. H., Au‐Yeung, A. W. S., & Loke, T. K. L. (2013) · Nuclear Medicine Review · doi:10.5603/nmr.2013.0039 · Cited by 14
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography–computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers
Uchiyama, S., Haruyama, Y., Asada, T., Hotokezaka, M., Nagamachi, S., & Chijiiwa, K. (2012) · Surgery Today · doi:10.1007/s00595-012-0225-6 · Cited by 14
18F-Deoxyglucose PET for the staging of oesophageal cancer
Döbert, N., Rieker, O., Kneist, W., Mose, S., Teising, A., Junginger, T., Böttcher, H. D., Bartenstein, P., Grünwald, F., & Menzel, C. (2003) · Nuklearmedizin - NuclearMedicine · doi:10.1055/s-0038-1625303 · Cited by 14
Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases
Masai, K., Sakurai, H., Suzuki, S., Asakura, K., Nakagawa, K., & WATANABE, S.-I. I. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24302 · Cited by 14
Pulmonary Mucinous Cystadenocarcinoma: Report a Case and Review of CT Findings
Choi, Y. A., Lee, H. Y., Han, J., Choi, J. Y., Kim, J., Kwon, O. J., & Lee, K. S. (2013) · Korean Journal of Radiology · doi:10.3348/kjr.2013.14.2.384 · Cited by 14
Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer
Honka, M., Rebelos, E., Malaspina, S., & Nuutila, P. (2022) · Metabolites · doi:10.3390/metabo12040321 · Cited by 14
FDG PET Imaging of Signet-Ring Cell Adenocarcinoma of the Stomach
Buyyounouski, M. K., Klump, W. J., Konski, A. A., Wu, H. Y., & Adler, L. P. (2005) · Clinical Nuclear Medicine · doi:10.1097/00003072-200502000-00014 · Cited by 13
FDG-PET and PET/CT in Colorectal Cancer
Lonneux, M. (2008) · PET Clinics · doi:10.1016/j.cpet.2008.08.004 · Cited by 13
Positron emission tomography for evaluation of colorectal carcinoma
Vitola, J. V., & Delbeke, D. (2002) · Seminars in Roentgenology · doi:10.1016/s0037-198x(02)80031-1 · Cited by 13
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis
Willemse, J. R. J., Lambregts, D. M. J., Balduzzi, S., Schats, W., Snæbjörnsson, P., Marchetti, S., Vollebergh, M. A., van Golen, L. W., Cheung, Z. J., Vogel, W. V., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06860-1 · Cited by 13
Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians
Karantanis, D., Kalkanis, D., Czernin, J. G., Herrmann, K., Pomykala, K. L., Bogsrud, T. V., Subramaniam, R. M., Lowe, V. J., & Allen-Auerbach, M. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.145607 · Cited by 12
PET/MRI Characterization of Mucinous Versus Nonmucinous Components of Rectal Adenocarcinoma: A Comparison of Tumor Metabolism and Cellularity
Queiroz, M. A., Naves, A., Dreyer, P. L., Cerri, G. G., & Buchpiguel, C. A. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.22627 · Cited by 12
Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors
Sasada, S., Kimura, Y., Masumoto, N., Emi, A., Kadoya, T., Arihiro, K., & Okada, M. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.02.026 · Cited by 12
Fluoro‐2‐deoxy‐ d ‐glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer
Kim, W. S., Lee, H. S., Lee, J., Kwak, M. S., Hwang, S. W., Park, S. H., Yang, D., Kim, K., Myung, S., Yang, S., et al. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13486 · Cited by 12
Hereditary diffuse gastric cancer: One family’s story
Zylberberg, H. M., Sultan, K. S., & Rubin, S. D. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i1.1 · Cited by 12
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma
Sánchez-Izquierdo, N., Perlaza, P., Pagès, M., Buxó, E., Ríos, J., Rubello, D., Colletti, P. M., Mayoral, M., Casanueva, S., Fernández‐Esparrach, G., et al. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002840 · Cited by 12
Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT
Kwon, H. R., Park, S. S., Park, S., Kwon, H. W., & Kim, S. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00622-w · Cited by 12
Mucinous Carcinoma of the Skin: Evaluation of Lymphatic Invasion With D2-40
Paradela, S., Castiñeiras, I., Cuevas, J., Almagro, M., del Pozo, J., & Fonseca, E. (2008) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e318170c3cf · Cited by 12
FDG PET/CT Findings of Urachal Abscess
Nakajo, M., Jinnouchi, S., Arimura, H., Kitajima, S., Tateno, R., & Nakajo, M. (2008) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31817dead5 · Cited by 12
Image-guided pelvic exenteration-preoperative and intraoperative strategies
Corr, A., Fletcher, J. A., Jenkins, J. T., & Mišković, D. (2022) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2022.08.002 · Cited by 11
Contribution of Metabolic Parameters and Pericolic Fat Stranding on Preoperative 18F-FDG PET/CT in Predicting Post-operative Histopathology and Outcome in Colorectal Cancer
Soyluoğlu, S., & Özdemir, B. (2023) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-023-00808-3 · Cited by 11
Surgical management of colorectal liver metastases: a European perspective
Dunne, D. F. J., Jones, R. P., Malik, H., Fenwick, S. W., & Poston, G. J. (2013) · Hepatic Oncology · doi:10.2217/hep.13.3 · Cited by 11
Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT
Puranik, A. D., Purandare, N. C., Agrawal, A., Shah, S. A., & Rangarajan, V. (2014) · Japanese Journal of Radiology · doi:10.1007/s11604-014-0346-5 · Cited by 11
Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma
Martínez‐Román, S., Ramirez, P. T., Oh, J. C., Viciedo, M. G., & Macapinlac, H. A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.045 · Cited by 11
Indeterminate lesions in cancer imaging
Spencer, J. A. D. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.11.025 · Cited by 11
Comparison of MRI and 18F-FDG PET/CT in the Liver Metastases of Gastrointestinal and Pancreaticobiliary Tumors
Tahtabaşı, M. (2020) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2020.80270 · Cited by 10
18F-fluorodeoxyglucose uptake in advanced gastric cancer correlates with histopathological subtypes and volume of tumor stroma
Seko‐Nitta, A., Nagatani, Y., Murakami, Y., Watanabe, Y., Nitta, N., Murata, K., Takemura, S., & Murata, S. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.110048 · Cited by 10
Colorectal Cancer: Preoperative Evaluation and Staging
Hayman, A. V., & Vasilevsky, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-66049-9_24 · Cited by 10
Impacto de la tomografía por emisión de positrones mediante 18-Fluoro-2-Desoxi-D-Glucosa (PET-FDG) en el manejo terapéutico de pacientes con recurrencia secundaria a cáncer de ovario
Ruíz-Hernández, G., Bolton, R. C. D., Fernández, C., Lapeña, L., Jiménez-Vicioso, A., Pérez-Castejón, M. A. J., Domper, M., Montz, R., & Delgado, J. L. C. (2005) · Revista Española de Medicina Nuclear · doi:10.1157/13071687 · Cited by 10
Value of 18F-FDG PET/CT Combined With Tumor Markers in the Evaluation of Ascites
Han, N., Sun, X., Qin, C., Bakari, K. H., Wu, Z., Zhang, Y., & Lan, X. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18733 · Cited by 10
Is There a Role For PET/CT With Esophagogastric Junction Adenocarcinoma?
Fuster, D., Mayoral, M., Rubello, D., Pineda, E., Fernández‐Esparrach, G., Pagès, M., Colletti, P. M., & Pons, F. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000661 · Cited by 9
Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose–positron emission tomography in stage IB cervical cancer
Lin, A. J., Wright, J. D., Dehdashti, F., Siegel, B. A., Markovina, S. T., Schwarz, J. K., Thaker, P. H., Mutch, D. G., Powell, M. A., & Grigsby, P. W. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000528 · Cited by 9
Self-citation
Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors
Menon, N., & Mandelkern, M. A. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07616-3 · Cited by 9
Detection of Synchronous Adenocarcinomas and Multiple Dysplastic Polyps with F-18 FDG Positron Emission Tomography in a Case of Nonfamilial Polyposis
PATRIKEOS, A., Mackay, J., & Hicks, R. J. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000067510.43457.52 · Cited by 9
The value of [18F]FDG PET/CT examination in the detection and differentiation of recurrent ovarian cancer
Kosińska, M., Misiewicz, P., Kalita, K., Fijuth, J., Foks, M., Kuncman, Ł., & Gottwald, L. M. (2023) · Nuclear Medicine Review · doi:10.5603/nmr.2023.0013 · Cited by 8
Gelatinous Degeneration of the Bone Marrow Mimicking Osseous Metastasis on 18F-FDG PET/CT
Chong, A., Song, H., Oh, J.-R., Ha, J., Min, J., Bom, H., Choi, Y. D., & Lee, J. S. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31825ae455 · Cited by 8
Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection?
Singhal, N., Vallam, K. C., Engineer, R. Z., Ostwal, V. S., Arya, S., & Saklani, A. P. (2016) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.01.08 · Cited by 8
Lower Gastrointestinal Tract Applications of PET/Computed Tomography and PET/MR Imaging
Catalano, O. A., Kilcoyne, A., Signore, A., Mahmood, U., & Rosen, B. R. (2018) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2018.05.001 · Cited by 8
18F-FDG PET/CT in Urachal Abscess
Flaus, A., Longo, M.-G., Dematons, M., Granjon, D., & Prévôt, N. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002524 · Cited by 8
Colorectal Cancer
Delbeke, D., & Walker, R. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-92820-3_7 · Cited by 8
PET/MRI in the Upper Abdomen
Gavra, M. M., Syed, R., Fraioli, F., Afaq, A., & Bomanji, J. B. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.03.002 · Cited by 8
PET/CT-MR Imaging in Head and Neck Cancer Including Pitfalls and Physiologic Variations
Loevner, L. A., Kim, A. K., & Mikityansky, I. (2008) · PET Clinics · doi:10.1016/j.cpet.2009.04.008 · Cited by 8
Carcinoma Associated with Anal Fistula: A Clinicopathologics Study in 15 Patients
Nakajima, K., Kobayashi, A., Koda, T., Minagawa, N., Nishizawa, Y., Nishizawa, Y., Ito, M., Sugito, M., Kojima, M., & Saito, N. (2010) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.63.346 · Cited by 8
FDG-Negative Signet Ring Cell Cancer of the Stomach With FDG-Positive Skin Metastases
Bhure, U., Schmitt, A. M., Pestalozzi, B. C., Hany, T. F., & Strobel, K. (2007) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000255241.97811.4d · Cited by 8
The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma
Kadhim, L. A.-R., Dholakia, A. S., Herman, J. M., Wahl, R. L., & Chaudhry, M. Q. (2013) · Journal of Radiation Oncology · doi:10.1007/s13566-013-0130-7 · Cited by 8
Tomografía por emisión de positrones/tomografía computarizada: artefactos y pitfalls en pacientes con cáncer
Sarasúa, L. G., Aizpurúa, J. E., & Raman, S. (2006) · Radiología · doi:10.1016/s0033-8338(06)73156-3 · Cited by 8
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma
Yang, Z.-Y., Hu, S.-L., Shi, W., Zhu, B.-L., Xu, J.-Y., & Zhang, Y.-J. (2011) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32834bbd22 · Cited by 8
Diagnostic Performance of F-18 FDG PET/CT in the Detection of Recurrent Colorectal Cancer: Correlation with Biochemical Markers and Conventional Imaging Modalities
Mihailovic, J. M., Roganovic, J., Starčević, I., Nikolić, I., Bunović, N. P., & Nikin, Z. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123602 · Cited by 7
Imaging Characteristics of a Mucinous Colorectal Pulmonary Metastasis
Belcher, E., Nicholson, A. G., Hansell, D. M., & Goldstraw, P. G. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.12.078 · Cited by 7
Usefulness of 18F-FDG PET/CT to Detect Metastatic Mucinous Adenocarcinoma Within an Inguinal Hernia
Seo, H. J., Min, B. W., Eo, J. S., Lee, S. I., Kang, S. H., Jung, S. Y., Oh, S. C., & Choe, J. G. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-015-0379-4 · Cited by 7
Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group
Aytaç, E., Aslan, F., Çıçek, B., Erdamar, S., Gürses, B., Güven, K., Falay, O., Karahasanoğlu, T., Selçukbırıcık, F., Selek, U., et al. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.18737 · Cited by 7
The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies
Selçuk, N. A., Beydağı, G., Akçay, K., Görmez, A., Toklu, T., & Kabasakal, L. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07597-1 · Cited by 6
Added value of body MRI to detect primary abdominal malignancies in the diagnostic work-up of patients with adenocarcinoma of unknown primary
Willemse, J. R. J., Lahaye, M. J., Goedegebuure, E. P., Snæbjörnsson, P., Marchetti, S., Vollebergh, M. A., van Golen, L. W., Vogel, W. V., Rostami, S., Bodalal, Z., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11149-w · Cited by 6
Unnecessary Surgery Can Be Avoided by Judicious Use of PET/CT Scanning in Colorectal Cancer Patients
Amin, A., Reddy, A., Wilson, R. G., Jha, M., Miranda, S., & Amin, J. (2012) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-012-9391-4 · Cited by 6

Authors: Berger, K. L., Nicholson, S. A., Dehdashti, F., & Siegel, B. A.
Affiliations: Washington University in St. Louis (US)
ORCID: Dehdashti, Farrokh
Siegel, Barry A.
Venue: American Journal of Roentgenology
Publisher: American Roentgen Ray Society
Published: 2000-04
Volume: 174
Issue: 4
Pages: 1005-1008
ISSN: 0002-9580 (ISSN-L)
0361-803X
1546-3141
DOI: 10.2214/ajr.174.4.1741005
OpenAlex: W1748631556
Cited by: 351
References: 25
Citations by year: 2026: 14 · 2025: 13 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 13 · 2020: 15 · 2019: 22 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 16 · 2013: 16 · 2012: 24
FWCI: 6.91
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Roentgenology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
Keywords: FDG-PET, mucinous carcinoma, 18F-fluorodeoxyglucose, tumor cellularity, false-negative results
MeSH terms: Adult, Aged, Adenocarcinoma, Mucinous, Female, Humans, Male, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Tomography, Emission-Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks